3
Announcements
Trials
Browse
Landscape
Status
Completed
86
Terminated
23
Unknown
17
Active not recruiting
6
Withdrawn
3
Recruiting
3
Not yet recruiting
2
Enrolling by invitation
1
Available
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
olverembatinib
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Imatinib Mesylate
×
Clear all
NCT06646978
2024-10-17
K2SPIRIT
Poitiers University Hospital
Enrolling by invitation
787 enrolled